Victoria Stuessel is 34- year-old wife and mother living with multiple sclerosis, a degenerative and progressively disabling disease of the Central Nervous System. Victoria is this month’s Price Fighting Hero for being a fierce patient advocate and an inspiration.
Under Scott Gottlieb’s leadership as the head of the Food and Drug Administration, the FDA has focused on bringing more generic drugs to market to compete with pricier name-brand drugs and help lower prescription drug prices.
In anticipation of the possible elimination of safe harbor exemption for drug rebates, Patients For Affordable Drugs encouraged the Trump administration to ensure that any rebate changes benefit patients, first and foremost.
“I have a message for Jeffrey Leiden, CEO of Vertex Pharmaceuticals: I’m dying and you could save me."
In light of the news that CMS will empower Medicare Advantage plans to negotiate for Part B drugs by using step therapy, Patients For Affordable Drugs President and Founder David Mitchell issued the following statement.
So much price gouging makes it tough to choose, so the patient advocacy group asked today for the public’s help.
President Donald Trump, Senator Bernie Sanders, and Americans across the country all agree: the federal government should negotiate lower prices for prescription drugs.
Merck looks for praise. Reporters get details. Patients won't see meaningful price decreases.
Patients For Affordable Drugs is the only independent national patient organization focused exclusively on achieving policy changes to lower the price of prescription drugs.
